<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>769</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>11858873</PubmedId>
            <Abstract>Understanding the antibody response in botulinum intoxication is important for vaccine design and passive prophylaxis. To investigate this activity, we have studied the immune response to BoNT/A (botulinum neurotoxin serotype A) binding domain (HC) at the molecular level using phage display. The scFv antibodies were isolated from V-gene repertoires prepared from (a) human volunteer immunized with pentavalent botulinum toxoid and (b) non-immune human peripheral blood lymphocytes and spleenocytes. A large panel of serotype specific phage expressing botulinum binding scFv could be selected from both libraries. Epitope mapping of immune scFv binders towards BoNT/A HC revealed surprisingly a limited number of scFv recognizing conformational epitopes that corresponded to two distinct groups, clusters I and II. Only scFv from cluster I exhibited neutralizing activity in the mouse hemidiaphragm assay. Anti- BoNT/A HC clones derived from a non-immune library could be conveniently grouped into clusters III-XI and appeared to share no overlapping epitopes with cluster I or II. In addition they showed no neutralization of toxin at biologically significant concentrations. We therefore suggest that a vaccine based on the pentavalent botulinum toxoid directs the humoral immune response to a limited number of immunodominant epitopes exposed on the binding domain HC.</Abstract>
            <ArticleYear>2002</ArticleYear>
            <ArticlePages>1640-8</ArticlePages>
            <ArticleTitle>Genetic and immunological comparison of anti-botulinum type A antibodies from immune and non-immune human phage libraries.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Amersdorfer</LastName>
                    <ForeName>Peter</ForeName>
                </Author>
                <Author>
                    <LastName>Wong</LastName>
                    <ForeName>Cindy</ForeName>
                </Author>
                <Author>
                    <LastName>Smith</LastName>
                    <ForeName>Theresa</ForeName>
                </Author>
                <Author>
                    <LastName>Chen</LastName>
                    <ForeName>Steven</ForeName>
                </Author>
                <Author>
                    <LastName>Deshpande</LastName>
                    <ForeName>Sharad</ForeName>
                </Author>
                <Author>
                    <LastName>Sheridan</LastName>
                    <ForeName>Robert</ForeName>
                </Author>
                <Author>
                    <LastName>Marks</LastName>
                    <ForeName>James D</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Anesthesia and Pharmaceutical Chemistry, San Francisco General Hospital, University of California, San Francisco Rm 3C-38, 1001 Potrero Avenue, San Francisco, CA 94110, USA. peter_amersdorfer@corvas.com.</Affiliations>
            <ArticleChemicalList>Antibodies, Bacterial;Antibodies, Monoclonal;Immunoglobulin Variable Region;Peptide Library;Botulinum Toxins, Type A</ArticleChemicalList>
            <ArticleMeshHeadingsList>Antibodies, Bacterial(genetics; immunology); Antibodies, Monoclonal(genetics; immunology); Botulinum Toxins, Type A(immunology; toxicity); Botulism(immunology; prevention &amp; control; therapy); Clostridium botulinum(immunology); Epitope Mapping; Humans; Immunoglobulin Variable Region(genetics; immunology); Neutralization Tests; Peptide Library</ArticleMeshHeadingsList>
            <Journal>
                <Volume>20</Volume>
                <Issue>11-12</Issue>
                <Title>Vaccine</Title>
                <Issn>1873-2518</Issn>
                <MedlineTa>Vaccine</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>H&lt;sub&gt;C&lt;/sub&gt; (binding) domain of Heavy chain of BoNT/A</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>RLLSTFTEYIKNIINTSILNLRYESNHLIDLSRYASKINIGSKVNFDPIDKNQIQLFNLESSKIEVILKNAIVYNSMYENFSTSFWIRIPKYFNSISLNNEYTIINCMENNSGWKVSLNYGEIIWTLQDTQEIKQRVVFKYSQMINISDYINRWIFVTITNNRLNNSKIYINGRLIDQKPISNLGNIHASNNIMFKLDGCRDTHRYIWIKYFNLFDKELNEKEIKDLYDNQSNSGILKDFWGDYLQYDKPYYMLNLYDPNKYVDVNNVGIRGYMYLKGPRGSVMTTNIYLNSSLYRGTKFIIKKYASGNKDNIVRNNDRVYINVVVKNKEYRLATNASQAGVEKILSALEIPDVGNLSQVVVMKSKNDQGITNKCKMNLQDNNGNDIGFIGFHQFNNIAKLVASNWYNRQIERSSRTLGCSWEFIPVDDGWGERPL</LinearSequence>
                        <StartingPosition>861</StartingPosition>
                        <EndingPosition>1296</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>54666</EpitopeId>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 3</LocationOfData>
                        <BCellId>1277209</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Botulinum neurotoxin type A precursor</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <DoseSchedule>4 doses at weeks 0,2,12 and 58 of 0.5ml pentavalent toxoid.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The immunogen is a mixture of 5 types of formaldehyde-inactivated BoNTs.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>263</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>0.00050</QuantitativeMeasurement>
                            <AssayComments>Affinity for the Hc domain was determined for a purified scFv fragment selected from a phage display library derived from a pentavalent toxoid-immunized donor. This scFv is also shown to bind Hc domain in ELISA and to have neutralizing activity of the holotoxin in an in vitro mouse hemidiafragm assay. 2 other scFv were found to be clonally related to this one by sequence analysis and to bind to the same or overlapping epitopes (referred to as cluster I) by competition for reactivity on the SPR chip.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Culture Supernatant</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>scFv</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>3D12</AssayedAntibodyName>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>H&lt;sub&gt;C&lt;/sub&gt; (binding) domain of Heavy chain of BoNT/A</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RLLSTFTEYIKNIINTSILNLRYESNHLIDLSRYASKINIGSKVNFDPIDKNQIQLFNLESSKIEVILKNAIVYNSMYENFSTSFWIRIPKYFNSISLNNEYTIINCMENNSGWKVSLNYGEIIWTLQDTQEIKQRVVFKYSQMINISDYINRWIFVTITNNRLNNSKIYINGRLIDQKPISNLGNIHASNNIMFKLDGCRDTHRYIWIKYFNLFDKELNEKEIKDLYDNQSNSGILKDFWGDYLQYDKPYYMLNLYDPNKYVDVNNVGIRGYMYLKGPRGSVMTTNIYLNSSLYRGTKFIIKKYASGNKDNIVRNNDRVYINVVVKNKEYRLATNASQAGVEKILSALEIPDVGNLSQVVVMKSKNDQGITNKCKMNLQDNNGNDIGFIGFHQFNNIAKLVASNWYNRQIERSSRTLGCSWEFIPVDDGWGERPL</LinearSequence>
                                        <StartingPosition>861</StartingPosition>
                                        <EndingPosition>1296</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 3</LocationOfData>
                        <BCellId>1277210</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Botulinum neurotoxin type A precursor</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <DoseSchedule>4 doses at weeks 0,2,12 and 58 of 0.5ml pentavalent toxoid.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The immunogen is a mixture of 5 types of formaldehyde-inactivated BoNTs.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>316</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Purified scFv fragment selected from a phage display library derived from a pentavalent toxoid-immunized donor, shown to bind Hc domain in ELISA has neutralizing activity of the holotoxin in an in vitro mouse hemidiafragm assay. 2 other scFv were found to be clonally related to this one by sequence analysis and to bind to the same or overlapping epitopes (referred to as cluster I) by competition for reactivity on the SPR chip. Another (cluster II) set of non-competing scFvs fails to neutralize the toxin.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Culture Supernatant</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>scFv</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>3D12</AssayedAntibodyName>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Botulinum neurotoxin type A precursor</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 3</LocationOfData>
                        <BCellId>1312624</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Botulinum neurotoxin type A precursor</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <DoseSchedule>4 doses at weeks 0,2,12 and 58 of 0.5ml pentavalent toxoid.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The immunogen is a mixture of 5 types of formaldehyde-inactivated BoNTs.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>316</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>A purified scFv fragment selected from a phage display library derived from a pentavalent toxoid-immunized donor, did not have  neutralizing activity of the holotoxin in an in vitro mouse hemidiafragm assay. A different scFv fragment derived from the same display library which binds a different cluster on the protein was able to neutralize toxin.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Culture Supernatant</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>scFv</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>3F10</AssayedAntibodyName>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Botulinum neurotoxin type A precursor</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 3</LocationOfData>
                        <BCellId>1277211</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Botulinum neurotoxin type A precursor</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <DoseSchedule>4 doses at weeks 0,2,12 and 58 of 0.5ml pentavalent toxoid.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The immunogen is a mixture of 5 types of formaldehyde-inactivated BoNTs.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>45</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7.8</QuantitativeMeasurement>
                            <AssayComments>Affinity for the Hc domain was determined for a purified scFv fragment selected from a phage display library derived from a pentavalent toxoid-immunized donor. Another scFv was found to be clonally related to this one by sequence analysis and to bind to the same or overlapping epitope (referred to as cluster II) by competition for reactivity on the SPR chip.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Culture Supernatant</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>scFv</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>3F10</AssayedAntibodyName>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>H&lt;sub&gt;C&lt;/sub&gt; (binding) domain of Heavy chain of BoNT/A</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RLLSTFTEYIKNIINTSILNLRYESNHLIDLSRYASKINIGSKVNFDPIDKNQIQLFNLESSKIEVILKNAIVYNSMYENFSTSFWIRIPKYFNSISLNNEYTIINCMENNSGWKVSLNYGEIIWTLQDTQEIKQRVVFKYSQMINISDYINRWIFVTITNNRLNNSKIYINGRLIDQKPISNLGNIHASNNIMFKLDGCRDTHRYIWIKYFNLFDKELNEKEIKDLYDNQSNSGILKDFWGDYLQYDKPYYMLNLYDPNKYVDVNNVGIRGYMYLKGPRGSVMTTNIYLNSSLYRGTKFIIKKYASGNKDNIVRNNDRVYINVVVKNKEYRLATNASQAGVEKILSALEIPDVGNLSQVVVMKSKNDQGITNKCKMNLQDNNGNDIGFIGFHQFNNIAKLVASNWYNRQIERSSRTLGCSWEFIPVDDGWGERPL</LinearSequence>
                                        <StartingPosition>861</StartingPosition>
                                        <EndingPosition>1296</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 3</LocationOfData>
                        <BCellId>1277212</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Botulinum neurotoxin type A precursor</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <DoseSchedule>4 doses at weeks 0,2,12 and 58 of 0.5ml pentavalent toxoid.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The immunogen is a mixture of 5 types of formaldehyde-inactivated BoNTs.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>262</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>80000.0</QuantitativeMeasurement>
                            <AssayComments>Affinity for the Hc domain was determined for a purified scFv fragment selected from a phage display library derived from a pentavalent toxoid-immunized donor. Another scFv was found to be clonally related to this one by sequence analysis and to bind to the same or overlapping epitope (referred to as cluster II) by competition for reactivity on the SPR chip.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Culture Supernatant</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>scFv</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>3F10</AssayedAntibodyName>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>H&lt;sub&gt;C&lt;/sub&gt; (binding) domain of Heavy chain of BoNT/A</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RLLSTFTEYIKNIINTSILNLRYESNHLIDLSRYASKINIGSKVNFDPIDKNQIQLFNLESSKIEVILKNAIVYNSMYENFSTSFWIRIPKYFNSISLNNEYTIINCMENNSGWKVSLNYGEIIWTLQDTQEIKQRVVFKYSQMINISDYINRWIFVTITNNRLNNSKIYINGRLIDQKPISNLGNIHASNNIMFKLDGCRDTHRYIWIKYFNLFDKELNEKEIKDLYDNQSNSGILKDFWGDYLQYDKPYYMLNLYDPNKYVDVNNVGIRGYMYLKGPRGSVMTTNIYLNSSLYRGTKFIIKKYASGNKDNIVRNNDRVYINVVVKNKEYRLATNASQAGVEKILSALEIPDVGNLSQVVVMKSKNDQGITNKCKMNLQDNNGNDIGFIGFHQFNNIAKLVASNWYNRQIERSSRTLGCSWEFIPVDDGWGERPL</LinearSequence>
                                        <StartingPosition>861</StartingPosition>
                                        <EndingPosition>1296</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 3</LocationOfData>
                        <BCellId>1277208</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Botulinum neurotoxin type A precursor</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <DoseSchedule>4 doses at weeks 0,2,12 and 58 of 0.5ml pentavalent toxoid.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The immunogen is a mixture of 5 types of formaldehyde-inactivated BoNTs.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>262</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>13000.0</QuantitativeMeasurement>
                            <AssayComments>Affinity for the Hc domain was determined for a purified scFv fragment selected from a phage display library derived from a pentavalent toxoid-immunized donor. This scFv is also shown to bind Hc domain in ELISA and to have neutralizing activity of the holotoxin in an in vitro mouse hemidiafragm assay. 2 other scFv were found to be clonally related to this one by sequence analysis and to bind to the same or overlapping epitopes (referred to as cluster I) by competition for reactivity on the SPR chip.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Culture Supernatant</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>scFv</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>3D12</AssayedAntibodyName>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>H&lt;sub&gt;C&lt;/sub&gt; (binding) domain of Heavy chain of BoNT/A</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RLLSTFTEYIKNIINTSILNLRYESNHLIDLSRYASKINIGSKVNFDPIDKNQIQLFNLESSKIEVILKNAIVYNSMYENFSTSFWIRIPKYFNSISLNNEYTIINCMENNSGWKVSLNYGEIIWTLQDTQEIKQRVVFKYSQMINISDYINRWIFVTITNNRLNNSKIYINGRLIDQKPISNLGNIHASNNIMFKLDGCRDTHRYIWIKYFNLFDKELNEKEIKDLYDNQSNSGILKDFWGDYLQYDKPYYMLNLYDPNKYVDVNNVGIRGYMYLKGPRGSVMTTNIYLNSSLYRGTKFIIKKYASGNKDNIVRNNDRVYINVVVKNKEYRLATNASQAGVEKILSALEIPDVGNLSQVVVMKSKNDQGITNKCKMNLQDNNGNDIGFIGFHQFNNIAKLVASNWYNRQIERSSRTLGCSWEFIPVDDGWGERPL</LinearSequence>
                                        <StartingPosition>861</StartingPosition>
                                        <EndingPosition>1296</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 3</LocationOfData>
                        <BCellId>1277214</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>No immunization</InVivoProcessType>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>159</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>For 10 soluble scFv obtained from a non-immune phage-displayed library, selected by binding to BoNT/A Hc, affinities towards that domain were determined to range from KDs of 4.6e-7 to 2.61e-8 M. While they also bind the holotoxin in ELISA, none of them had neutralizing activity on the toxin in a mouse hemidiafragm in vitro assay.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Culture Supernatant</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>scFv</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>2A9, 2A2, 2B10, 3F6, 2B1,3D1,2B6,2E6,2H6, 3C2</AssayedAntibodyName>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>H&lt;sub&gt;C&lt;/sub&gt; (binding) domain of Heavy chain of BoNT/A</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RLLSTFTEYIKNIINTSILNLRYESNHLIDLSRYASKINIGSKVNFDPIDKNQIQLFNLESSKIEVILKNAIVYNSMYENFSTSFWIRIPKYFNSISLNNEYTIINCMENNSGWKVSLNYGEIIWTLQDTQEIKQRVVFKYSQMINISDYINRWIFVTITNNRLNNSKIYINGRLIDQKPISNLGNIHASNNIMFKLDGCRDTHRYIWIKYFNLFDKELNEKEIKDLYDNQSNSGILKDFWGDYLQYDKPYYMLNLYDPNKYVDVNNVGIRGYMYLKGPRGSVMTTNIYLNSSLYRGTKFIIKKYASGNKDNIVRNNDRVYINVVVKNKEYRLATNASQAGVEKILSALEIPDVGNLSQVVVMKSKNDQGITNKCKMNLQDNNGNDIGFIGFHQFNNIAKLVASNWYNRQIERSSRTLGCSWEFIPVDDGWGERPL</LinearSequence>
                                        <StartingPosition>861</StartingPosition>
                                        <EndingPosition>1296</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 1, figure 1</LocationOfData>
                        <BCellId>1277206</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Botulinum neurotoxin type A precursor</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <DoseSchedule>4 doses at weeks 0,2,12 and 58 of 0.5ml pentavalent toxoid.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The immunogen is a mixture of 5 types of formaldehyde-inactivated BoNTs.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Of 23 anti-BONT/A soluble scFv, obtained from a phage-displayed library derived from a pentavalent toxoid-immunized individual, 6 were found to bind the Hc (binding) domain.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Culture Supernatant</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>scFv</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>3A6, 3D12, 2A1, 3B8, 3F10, 2B11</AssayedAntibodyName>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>H&lt;sub&gt;C&lt;/sub&gt; (binding) domain of Heavy chain of BoNT/A</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RLLSTFTEYIKNIINTSILNLRYESNHLIDLSRYASKINIGSKVNFDPIDKNQIQLFNLESSKIEVILKNAIVYNSMYENFSTSFWIRIPKYFNSISLNNEYTIINCMENNSGWKVSLNYGEIIWTLQDTQEIKQRVVFKYSQMINISDYINRWIFVTITNNRLNNSKIYINGRLIDQKPISNLGNIHASNNIMFKLDGCRDTHRYIWIKYFNLFDKELNEKEIKDLYDNQSNSGILKDFWGDYLQYDKPYYMLNLYDPNKYVDVNNVGIRGYMYLKGPRGSVMTTNIYLNSSLYRGTKFIIKKYASGNKDNIVRNNDRVYINVVVKNKEYRLATNASQAGVEKILSALEIPDVGNLSQVVVMKSKNDQGITNKCKMNLQDNNGNDIGFIGFHQFNNIAKLVASNWYNRQIERSSRTLGCSWEFIPVDDGWGERPL</LinearSequence>
                                        <StartingPosition>861</StartingPosition>
                                        <EndingPosition>1296</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 1, figure 1</LocationOfData>
                        <BCellId>1312623</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Botulinum neurotoxin type A precursor</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <DoseSchedule>4 doses at weeks 0,2,12 and 58 of 0.5ml pentavalent toxoid.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The immunogen is a mixture of 5 types of formaldehyde-inactivated BoNTs.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Of 23 epitopic region specific monoclonal soluble scFv, obtained from a phage-displayed library derived from a pentavalent toxoid-immunized individual, all recognized BoNT/A.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Culture Supernatant</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>scFv</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>3A6, 3D12, 2A1, 3B8, 3F10, 2B11</AssayedAntibodyName>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Botulinum neurotoxin type A precursor</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 3</LocationOfData>
                        <BCellId>1277207</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Botulinum neurotoxin type A precursor</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <DoseSchedule>4 doses at weeks 0,2,12 and 58 of 0.5ml pentavalent toxoid.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The immunogen is a mixture of 5 types of formaldehyde-inactivated BoNTs.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>45</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>36.9</QuantitativeMeasurement>
                            <AssayComments>Affinity for the Hc domain was determined for a purified scFv fragment selected from a phage display library derived from a pentavalent toxoid-immunized donor. This scFv is also shown to bind Hc domain in ELISA and to have neutralizing activity of the holotoxin in an in vitro mouse hemidiafragm assay. 2 other scFv were found to be clonally related to this one by sequence analysis and to bind to the same or overlapping epitopes (referred to as cluster I) by competition for reactivity on the SPR chip.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Culture Supernatant</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>scFv</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>3D12</AssayedAntibodyName>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>H&lt;sub&gt;C&lt;/sub&gt; (binding) domain of Heavy chain of BoNT/A</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RLLSTFTEYIKNIINTSILNLRYESNHLIDLSRYASKINIGSKVNFDPIDKNQIQLFNLESSKIEVILKNAIVYNSMYENFSTSFWIRIPKYFNSISLNNEYTIINCMENNSGWKVSLNYGEIIWTLQDTQEIKQRVVFKYSQMINISDYINRWIFVTITNNRLNNSKIYINGRLIDQKPISNLGNIHASNNIMFKLDGCRDTHRYIWIKYFNLFDKELNEKEIKDLYDNQSNSGILKDFWGDYLQYDKPYYMLNLYDPNKYVDVNNVGIRGYMYLKGPRGSVMTTNIYLNSSLYRGTKFIIKKYASGNKDNIVRNNDRVYINVVVKNKEYRLATNASQAGVEKILSALEIPDVGNLSQVVVMKSKNDQGITNKCKMNLQDNNGNDIGFIGFHQFNNIAKLVASNWYNRQIERSSRTLGCSWEFIPVDDGWGERPL</LinearSequence>
                                        <StartingPosition>861</StartingPosition>
                                        <EndingPosition>1296</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 3</LocationOfData>
                        <BCellId>1277213</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Botulinum neurotoxin type A precursor</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <DoseSchedule>4 doses at weeks 0,2,12 and 58 of 0.5ml pentavalent toxoid.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The immunogen is a mixture of 5 types of formaldehyde-inactivated BoNTs.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>263</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>0.00062</QuantitativeMeasurement>
                            <AssayComments>Affinity for the Hc domain was determined for a purified scFv fragment selected from a phage display library derived from a pentavalent toxoid-immunized donor. Another scFv was found to be clonally related to this one by sequence analysis and to bind to the same or overlapping epitope (referred to as cluster II) by competition for reactivity on the SPR chip.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Culture Supernatant</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>scFv</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>3F10</AssayedAntibodyName>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>H&lt;sub&gt;C&lt;/sub&gt; (binding) domain of Heavy chain of BoNT/A</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RLLSTFTEYIKNIINTSILNLRYESNHLIDLSRYASKINIGSKVNFDPIDKNQIQLFNLESSKIEVILKNAIVYNSMYENFSTSFWIRIPKYFNSISLNNEYTIINCMENNSGWKVSLNYGEIIWTLQDTQEIKQRVVFKYSQMINISDYINRWIFVTITNNRLNNSKIYINGRLIDQKPISNLGNIHASNNIMFKLDGCRDTHRYIWIKYFNLFDKELNEKEIKDLYDNQSNSGILKDFWGDYLQYDKPYYMLNLYDPNKYVDVNNVGIRGYMYLKGPRGSVMTTNIYLNSSLYRGTKFIIKKYASGNKDNIVRNNDRVYINVVVKNKEYRLATNASQAGVEKILSALEIPDVGNLSQVVVMKSKNDQGITNKCKMNLQDNNGNDIGFIGFHQFNNIAKLVASNWYNRQIERSSRTLGCSWEFIPVDDGWGERPL</LinearSequence>
                                        <StartingPosition>861</StartingPosition>
                                        <EndingPosition>1296</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>H&lt;sub&gt;N&lt;/sub&gt; (translocation) domain of Heavy chain of BoNT/A</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ALNDLCIKVNNWDLFFSPSEDNFTNDLNKGEEITSDTNIEAAEENISLDLIQQYYLTFNFDNEPENISIENLSSDIIGQLELMPNIERFPNGKKYELDKYTMFHYLRAQEFEHGKSRIALTNSVNEALLNPSRVYTFFSSDYVKKVNKATEAAMFLGWVEQLVYDFTDETSEVSTTDKIADITIIIPYIGPALNIGNMLYKDDFVGALIFSGAVILLEFIPEIAIPVLGTFALVSYIANKVLTVQTIDNALSKRNEKWDEVYKYIVTNWLAKVNTQIDLIRKKMKEALENQAEATKAIINYQYNQYTEEEKNNINFNIDDLSSKLNESINKAMININKFLNQCSVSYLMNSMIPYGVKRLEDFDASLKDALLKYIYDNRGTLIGQVDRLKDKVNNTLSTDIPFQLSKYVDNQ</LinearSequence>
                        <StartingPosition>449</StartingPosition>
                        <EndingPosition>860</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>2774</EpitopeId>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 1, Figure 1</LocationOfData>
                        <BCellId>1277217</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Botulinum neurotoxin type A precursor</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <DoseSchedule>4 doses at weeks 0,2,12 and 58 of 0.5ml pentavalent toxoid.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The immunogen is a mixture of 5 types of formaldehyde-inactivated BoNTs.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Of 23 anti-BONT/A soluble scFv, obtained from a phage-displayed library derived from a pentavalent toxoid-immunized individual, 4 were found to bind the Hc (binding) domain.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Culture Supernatant</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>scFv</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>3D4, 3A11, 4A4, 3G4</AssayedAntibodyName>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>H&lt;sub&gt;N&lt;/sub&gt; (translocation) domain of Heavy chain of BoNT/A</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ALNDLCIKVNNWDLFFSPSEDNFTNDLNKGEEITSDTNIEAAEENISLDLIQQYYLTFNFDNEPENISIENLSSDIIGQLELMPNIERFPNGKKYELDKYTMFHYLRAQEFEHGKSRIALTNSVNEALLNPSRVYTFFSSDYVKKVNKATEAAMFLGWVEQLVYDFTDETSEVSTTDKIADITIIIPYIGPALNIGNMLYKDDFVGALIFSGAVILLEFIPEIAIPVLGTFALVSYIANKVLTVQTIDNALSKRNEKWDEVYKYIVTNWLAKVNTQIDLIRKKMKEALENQAEATKAIINYQYNQYTEEEKNNINFNIDDLSSKLNESINKAMININKFLNQCSVSYLMNSMIPYGVKRLEDFDASLKDALLKYIYDNRGTLIGQVDRLKDKVNNTLSTDIPFQLSKYVDNQ</LinearSequence>
                                        <StartingPosition>449</StartingPosition>
                                        <EndingPosition>860</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

